SCHEMBL3246624

SCHEMBL3246624

CS(=O)(=O)c1ccc(-c2c(-c3ccc(Cl)cc3)nc3sc(Cl)cn23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 1.00
PTGS1 P23219 2/20 0.52
CHEK2 O96017 2/20 0.47
RPS6KA3 P51812 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7837508 0.92 PTGS2 (0.84) PTGS2PTGS1
SCHEMBL5616866 0.79 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL3247750 0.78 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL7836982 0.78 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL3245733 0.77 PTGS2 (0.77) PTGS2PTGS1
SCHEMBL7835519 0.74 PTGS2 (0.72) PTGS2PTGS1
SCHEMBL5261561 0.72 KDM4E (0.59) PTGS2PTGS1
SCHEMBL7220519 0.72 KDM4E (0.59) PTGS2PTGS1
SCHEMBL5345880 0.71 PTGS2 (0.55) PTGS2PTGS1
SCHEMBL7714593 0.71 PTGS2 (0.55) PTGS2CHEK2RPS6KA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1390026-B1 TREATMENT OF HPV CAUSED DISEASES CORNELL RES FOUNDATION INC (US) 2010-05-05 EP claimed
EP-0802917-B1 ARYL SUBSTITUTED 5,5 FUSED AROMATIC NITROGEN COMPOUNDS AS ANTI-INFLAMMATORY AGENTS MERCK FROSST CANADA INC (CA) 2001-11-07 EP claimed
EP-0802917-A1 ARYL SUBSTITUTED 5,5 FUSED AROMATIC NITROGEN COMPOUNDS AS ANTI-INFLAMMATORY AGENTS MERCK FROSST CANADA INC. (CA) 1997-10-29 EP claimed
US-5552422-A Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents MERCK FROSST CANADA, INC. (CA) 1996-09-03 US claimed
WO-1996021667-A1 ARYL SUBSTITUTED 5,5 FUSED AROMATIC NITROGEN COMPOUNDS AS ANTI-INFLAMMATORY AGENTS MERCK FROSST CANADA INC. (CA) 1996-07-18 WO claimed
CN-117877625-A Virtual screening method for inhibitor MPB with human cyclooxygenase 2 as target and inhibitor thereof 重庆医科大学国际体外诊断研究院 2024-04-12 CN disclosed
EP-1039914-A4 CYCLOOXYGENASE-2 INHIBITION CORNELL RES FOUNDATION INC (US) 2007-06-27 EP disclosed
US-7041694-B1 Cyclooxygenase-2 inhibition CORNELL RESEARCH FOUNDATION, INC. (US) 2006-05-09 US disclosed
EP-1109553-A4 TREATING INFLAMMATORY DISEASES OF THE HEAD AND NECK WITH CYCLOOXYGENASE-2 INHIBITORS CORNELL RES FOUNDATION INC (US) 2003-12-10 EP disclosed
US-6486203-B1 Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors CORNELL RESEARCH FOUNDATION, INC. 2002-11-26 US disclosed
US-6403630-B1 ADMINISTERING A CYCLOOXYGENASE-2 (COX-2) INHIBITOR ALONE OR IN COMBINATION WITH HERCEPTIN? ANTIBODY; USED TO TREAT BREAST CANCER CORNELL RESEARCH FOUNDATION, INC. 2002-06-11 US disclosed
EP-0802917-B1 ARYL SUBSTITUTED 5,5 FUSED AROMATIC NITROGEN COMPOUNDS AS ANTI-INFLAMMATORY AGENTS MERCK FROSST CANADA INC (CA) 2001-11-07 EP disclosed
EP-1109553-A1 TREATING INFLAMMATORY DISEASES OF THE HEAD AND NECK WITH CYCLOOXYGENASE-2 INHIBITORS CORNELL RESEARCH FOUNDATION, INC. (US) 2001-06-27 EP disclosed
EP-1039914-A1 CYCLOOXYGENASE-2 INHIBITION CORNELL RESEARCH FOUNDATION, INC. (US) 2000-10-04 EP disclosed
WO-2000013685-A1 TREATING INFLAMMATORY DISEASES OF THE HEAD AND NECK WITH CYCLOOXYGENASE-2 INHIBITORS CORNELL RESEARCH FOUNDATION, INC. (US) 2000-03-16 WO disclosed
WO-1999030721-A1 CYCLOOXYGENASE-2 INHIBITION CORNELL RESEARCH FOUNDATION, INC. (US) 1999-06-24 WO disclosed
US-5552422-A Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents MERCK FROSST CANADA, INC. (CA) 1996-09-03 US disclosed